Sfoglia per Autore D'ALESSIO, Andrea
Effective and organ doses in patient undergoing interventional neuroradiology procedures: A multicentre study
2024-01-01 D'Alessio, Andrea; Strocchi, Sabina; Dalmasso, Federico; Cannillo, Barbara; Matheoud, Roberta; Ponzetti, Alex; Aimonetto, Stefania; Cernigliaro, Massimiliano; Azzalin, Giulia; Giorgianni, Andrea; Natrella, Massimiliano; Carriero, Alessandro; Guzzardi, Giuseppe; Brambilla, Marco
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
2023-01-01 Vithayathil, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Zanuso, V.; Pressiani, T.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J.; Sharma, R.
Cumulative radiation exposure from radiological imaging in patients with Hodgkin and diffuse large b-cell lymphoma not submitted to radiotherapy
2023-01-01 Brambilla, Marco; Matheoud, Roberta; Margiotta-Casaluci, Gloria; Cannillo, Barbara; D'Alessio, Andrea; Siciliano, Chiara; Carriero, Alessandro; Gaidano, Gianluca
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma
2023-01-01 Pinato, D. J.; Kaneko, T.; D'Alessio, A.; Forner, A.; Fessas, P.; Minguez, B.; Giannini, E. G.; Grillo, F.; Diaz, A.; Mauri, F. A.; Fulgenzi, C. A. M.; Dalla Pria, A.; Goldin, R. D.; Pieri, G.; Toniutto, P.; Avellini, C.; Plaz Torres, M. C.; Akarca, A. U.; Marafioti, T.; Bhoori, S.; Miro, J. M.; Bower, M.; Brau, N.; Mazzaferro, V.
PETAL protocol: A phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma
2023-01-01 Fessas, P.; Scheiner, B.; D'Alessio, A.; M Fulgenzi, C. A.; Korolewicz, J.; Ward, C.; Tait, P.; Thomas, R.; Cortellini, A.; Sharma, R.; Pinato, D. J.
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
2023-01-01 Scheiner, B.; Roessler, D.; Phen, S.; Lim, M.; Pomej, K.; Pressiani, T.; Cammarota, A.; Frundt, T. W.; von Felden, J.; Schulze, K.; Himmelsbach, V.; Finkelmeier, F.; Deibel, A.; Siebenhuner, A. R.; Shmanko, K.; Radu, P.; Schwacha-Eipper, B.; Ebert, M. P.; Teufel, A.; Djanani, A.; Hucke, F.; Balcar, L.; Philipp, A. B.; Hsiehchen, D.; Venerito, M.; Sinner, F.; Trauner, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Pinato, D. J.; Peck-Radosavljevic, M.; Dufour, J. -F.; Weinmann, A.; Kremer, A. E.; Singal, A. G.; De Toni, E. N.; Rimassa, L.; Pinter, M.
. Optimisation of protection in the medical exposure of recurrent adult patients due to computed tomography procedures: development of recurrent exposures reference levels.
2023-01-01 Bramilla, M; Berton, L; Balzano, Rf; Cannillo, B; Carriero, A; Chauvie, S; Gallo, T; Cornacchia, S; Cutaia, C; D'Alessio, A; Emanuele, R; Fonio, P; Matheoud, R; Stasi, M; Talenti, A; Rampado, O.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
2023-01-01 Talbot, T.; D'Alessio, A.; Pinter, M.; Balcar, L.; Scheiner, B.; Marron, T. U.; Jun, T.; Dharmapuri, S.; Ang, C.; Saeed, A.; Hildebrand, H.; Muzaffar, M.; Fulgenzi, C. A. M.; Amara, S.; Naqash, A. R.; Gampa, A.; Pillai, A.; Wang, Y.; Khan, U.; Lee, P. -C.; Huang, Y. -H.; Bengsch, B.; Bettinger, D.; Mohamed, Y. I.; Kaseb, A.; Pressiani, T.; Personeni, N.; Rimassa, L.; Nishida, N.; Kudo, M.; Weinmann, A.; Galle, P. R.; Muhammed, A.; Cortellini, A.; Vogel, A.; Pinato, D. J.
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma
2023-01-01 Pinato, D. J.; Li, X.; Mishra-Kalyani, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Scheiner, B.; Pinter, M.; Wei, G.; Schneider, J.; Rivera, D. R.; Pazdur, R.; Theoret, M. R.; Casak, S.; Lemery, S.; Fashoyin-Aje, L.; Cortellini, A.; Pelosof, L.
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
2022-01-01 Fulgenzi, C. A. M.; Cheon, J.; D'Alessio, A.; Nishida, N.; Ang, C.; Marron, T. U.; Wu, L.; Saeed, A.; Wietharn, B.; Cammarota, A.; Pressiani, T.; Personeni, N.; Pinter, M.; Scheiner, B.; Balcar, L.; Napolitano, A.; Huang, Y. -H.; Phen, S.; Naqash, A. R.; Vivaldi, C.; Salani, F.; Masi, G.; Bettinger, D.; Vogel, A.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Kudo, M.; Rimassa, L.; Singal, A. G.; Sharma, R.; Cortellini, A.; Gaillard, V. E.; Chon, H. J.; Pinato, D. J.
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
2022-01-01 Marinelli, B.; Kim, E.; D'Alessio, A.; Cedillo, M.; Sinha, I.; Debnath, N.; Kudo, M.; Nishida, N.; Saeed, A.; Hildebrand, H.; Kaseb, A. O.; Abugabal, Y. I.; Pillai, A.; Huang, Y. -H.; Khan, U.; Muzaffar, M.; Naqash, A. R.; Patel, R.; Fischman, A.; Bishay, V.; Bettinger, D.; Sung, M.; Ang, C.; Schwartz, M.; Pinato, D. J.; Marron, T.
Reply
2022-01-01 D'Alessio, A.; Fulgenzi, C. A. M.; Pinato, D. J.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
2022-01-01 Vithayathil, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Personeni, N.; Pressiani, T.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J.; Sharma, R.
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions
2022-01-01 Cortellini, A.; Barrichello, A. P. C.; Alessi, J. V.; Ricciuti, B.; Vaz, V. R.; Newsom-Davis, T.; Evans, J. S.; Lamberti, G.; Pecci, F.; Viola, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Awad, M. M.; Pinato, D. J.
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?
2022-01-01 Fulgenzi, C. A. M.; D'Alessio, A.; Ogunbiyi, O.; Demirtas, C. O.; Gennari, A.; Cortellini, A.; Sharma, R.; Pinato, D. J.
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials
2022-01-01 Fulgenzi, C. A. M.; D'Alessio, A.; Airoldi, C.; Scotti, L.; Demirtas, C. O.; Gennari, A.; Cortellini, A.; Pinato, D. J.
The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma
2022-01-01 Muhammed, A.; Fulgenzi, C. A. M.; Dharmapuri, S.; Pinter, M.; Balcar, L.; Scheiner, B.; Marron, T. U.; Jun, T.; Saeed, A.; Hildebrand, H.; Muzaffar, M.; Navaid, M.; Naqash, A. R.; Gampa, A.; Ozbek, U.; Lin, J. -Y.; Perone, Y.; Vincenzi, B.; Silletta, M.; Pillai, A.; Wang, Y.; Khan, U.; Huang, Y. -H.; Bettinger, D.; Abugabal, Y. I.; Kaseb, A.; Pressiani, T.; Personeni, N.; Rimassa, L.; Nishida, N.; Tommaso, L. D.; Kudo, M.; Vogel, A.; Mauri, F. A.; Cortellini, A.; Sharma, R.; D'Alessio, A.; Ang, C.; Pinato, D. J.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study
2022-01-01 D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Gaillard, V. E.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Personeni, N.; Pressiani, T.; Sharma, R.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J.
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma
2022-01-01 Barsch, M; Salié, H; Schlaak, Ae; Zhang, Z; Hess, M; Mayer, Ls; Tauber, C; Otto-Mora, P; Ohtani, T; Nilsson, T; Wischer, L; Winkler, F; Manne, S; Rech, A; Schmitt-Graeff, A; Bronsert, P; Hofmann, M; Neumann-Haefelin, C; Boettler, T; Fichtner-Feigl, S; van Boemmel, F; Berg, T; Rimassa, L; Di Tommaso, L; Saeed, A; D'Alessio, A; Pinato, Dj; Bettinger, D; Binder, H; John Wherry, E; Schultheiss, M; Thimme, R; Bengsch, B.
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma
2022-01-01 Muhammed, A.; D'Alessio, A.; Enica, A.; Talbot, T.; Fulgenzi, C. A. M.; Nteliopoulos, G.; Goldin, R. D.; Cortellini, A.; Pinato, D. J.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Effective and organ doses in patient undergoing interventional neuroradiology procedures: A multicentre study | 1-gen-2024 | D'Alessio, Andrea; Strocchi, Sabina; Dalmasso, Federico; Cannillo, Barbara; Matheoud, Roberta; Ponzetti, Alex; Aimonetto, Stefania; Cernigliaro, Massimiliano; Azzalin, Giulia; Giorgianni, Andrea; Natrella, Massimiliano; Carriero, Alessandro; Guzzardi, Giuseppe; Brambilla, Marco | |
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma | 1-gen-2023 | Vithayathil, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Zanuso, V.; Pressiani, T.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J.; Sharma, R. | |
Cumulative radiation exposure from radiological imaging in patients with Hodgkin and diffuse large b-cell lymphoma not submitted to radiotherapy | 1-gen-2023 | Brambilla, Marco; Matheoud, Roberta; Margiotta-Casaluci, Gloria; Cannillo, Barbara; D'Alessio, Andrea; Siciliano, Chiara; Carriero, Alessandro; Gaidano, Gianluca | |
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma | 1-gen-2023 | Pinato, D. J.; Kaneko, T.; D'Alessio, A.; Forner, A.; Fessas, P.; Minguez, B.; Giannini, E. G.; Grillo, F.; Diaz, A.; Mauri, F. A.; Fulgenzi, C. A. M.; Dalla Pria, A.; Goldin, R. D.; Pieri, G.; Toniutto, P.; Avellini, C.; Plaz Torres, M. C.; Akarca, A. U.; Marafioti, T.; Bhoori, S.; Miro, J. M.; Bower, M.; Brau, N.; Mazzaferro, V. | |
PETAL protocol: A phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma | 1-gen-2023 | Fessas, P.; Scheiner, B.; D'Alessio, A.; M Fulgenzi, C. A.; Korolewicz, J.; Ward, C.; Tait, P.; Thomas, R.; Cortellini, A.; Sharma, R.; Pinato, D. J. | |
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma | 1-gen-2023 | Scheiner, B.; Roessler, D.; Phen, S.; Lim, M.; Pomej, K.; Pressiani, T.; Cammarota, A.; Frundt, T. W.; von Felden, J.; Schulze, K.; Himmelsbach, V.; Finkelmeier, F.; Deibel, A.; Siebenhuner, A. R.; Shmanko, K.; Radu, P.; Schwacha-Eipper, B.; Ebert, M. P.; Teufel, A.; Djanani, A.; Hucke, F.; Balcar, L.; Philipp, A. B.; Hsiehchen, D.; Venerito, M.; Sinner, F.; Trauner, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Pinato, D. J.; Peck-Radosavljevic, M.; Dufour, J. -F.; Weinmann, A.; Kremer, A. E.; Singal, A. G.; De Toni, E. N.; Rimassa, L.; Pinter, M. | |
. Optimisation of protection in the medical exposure of recurrent adult patients due to computed tomography procedures: development of recurrent exposures reference levels. | 1-gen-2023 | Bramilla, M; Berton, L; Balzano, Rf; Cannillo, B; Carriero, A; Chauvie, S; Gallo, T; Cornacchia, S; Cutaia, C; D'Alessio, A; Emanuele, R; Fonio, P; Matheoud, R; Stasi, M; Talenti, A; Rampado, O. | |
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study | 1-gen-2023 | Talbot, T.; D'Alessio, A.; Pinter, M.; Balcar, L.; Scheiner, B.; Marron, T. U.; Jun, T.; Dharmapuri, S.; Ang, C.; Saeed, A.; Hildebrand, H.; Muzaffar, M.; Fulgenzi, C. A. M.; Amara, S.; Naqash, A. R.; Gampa, A.; Pillai, A.; Wang, Y.; Khan, U.; Lee, P. -C.; Huang, Y. -H.; Bengsch, B.; Bettinger, D.; Mohamed, Y. I.; Kaseb, A.; Pressiani, T.; Personeni, N.; Rimassa, L.; Nishida, N.; Kudo, M.; Weinmann, A.; Galle, P. R.; Muhammed, A.; Cortellini, A.; Vogel, A.; Pinato, D. J. | |
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma | 1-gen-2023 | Pinato, D. J.; Li, X.; Mishra-Kalyani, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Scheiner, B.; Pinter, M.; Wei, G.; Schneider, J.; Rivera, D. R.; Pazdur, R.; Theoret, M. R.; Casak, S.; Lemery, S.; Fashoyin-Aje, L.; Cortellini, A.; Pelosof, L. | |
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study | 1-gen-2022 | Fulgenzi, C. A. M.; Cheon, J.; D'Alessio, A.; Nishida, N.; Ang, C.; Marron, T. U.; Wu, L.; Saeed, A.; Wietharn, B.; Cammarota, A.; Pressiani, T.; Personeni, N.; Pinter, M.; Scheiner, B.; Balcar, L.; Napolitano, A.; Huang, Y. -H.; Phen, S.; Naqash, A. R.; Vivaldi, C.; Salani, F.; Masi, G.; Bettinger, D.; Vogel, A.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Kudo, M.; Rimassa, L.; Singal, A. G.; Sharma, R.; Cortellini, A.; Gaillard, V. E.; Chon, H. J.; Pinato, D. J. | |
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study | 1-gen-2022 | Marinelli, B.; Kim, E.; D'Alessio, A.; Cedillo, M.; Sinha, I.; Debnath, N.; Kudo, M.; Nishida, N.; Saeed, A.; Hildebrand, H.; Kaseb, A. O.; Abugabal, Y. I.; Pillai, A.; Huang, Y. -H.; Khan, U.; Muzaffar, M.; Naqash, A. R.; Patel, R.; Fischman, A.; Bishay, V.; Bettinger, D.; Sung, M.; Ang, C.; Schwartz, M.; Pinato, D. J.; Marron, T. | |
Reply | 1-gen-2022 | D'Alessio, A.; Fulgenzi, C. A. M.; Pinato, D. J. | |
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma | 1-gen-2022 | Vithayathil, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Personeni, N.; Pressiani, T.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J.; Sharma, R. | |
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions | 1-gen-2022 | Cortellini, A.; Barrichello, A. P. C.; Alessi, J. V.; Ricciuti, B.; Vaz, V. R.; Newsom-Davis, T.; Evans, J. S.; Lamberti, G.; Pecci, F.; Viola, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Awad, M. M.; Pinato, D. J. | |
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape? | 1-gen-2022 | Fulgenzi, C. A. M.; D'Alessio, A.; Ogunbiyi, O.; Demirtas, C. O.; Gennari, A.; Cortellini, A.; Sharma, R.; Pinato, D. J. | |
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials | 1-gen-2022 | Fulgenzi, C. A. M.; D'Alessio, A.; Airoldi, C.; Scotti, L.; Demirtas, C. O.; Gennari, A.; Cortellini, A.; Pinato, D. J. | |
The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma | 1-gen-2022 | Muhammed, A.; Fulgenzi, C. A. M.; Dharmapuri, S.; Pinter, M.; Balcar, L.; Scheiner, B.; Marron, T. U.; Jun, T.; Saeed, A.; Hildebrand, H.; Muzaffar, M.; Navaid, M.; Naqash, A. R.; Gampa, A.; Ozbek, U.; Lin, J. -Y.; Perone, Y.; Vincenzi, B.; Silletta, M.; Pillai, A.; Wang, Y.; Khan, U.; Huang, Y. -H.; Bettinger, D.; Abugabal, Y. I.; Kaseb, A.; Pressiani, T.; Personeni, N.; Rimassa, L.; Nishida, N.; Tommaso, L. D.; Kudo, M.; Vogel, A.; Mauri, F. A.; Cortellini, A.; Sharma, R.; D'Alessio, A.; Ang, C.; Pinato, D. J. | |
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study | 1-gen-2022 | D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Gaillard, V. E.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Personeni, N.; Pressiani, T.; Sharma, R.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J. | |
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma | 1-gen-2022 | Barsch, M; Salié, H; Schlaak, Ae; Zhang, Z; Hess, M; Mayer, Ls; Tauber, C; Otto-Mora, P; Ohtani, T; Nilsson, T; Wischer, L; Winkler, F; Manne, S; Rech, A; Schmitt-Graeff, A; Bronsert, P; Hofmann, M; Neumann-Haefelin, C; Boettler, T; Fichtner-Feigl, S; van Boemmel, F; Berg, T; Rimassa, L; Di Tommaso, L; Saeed, A; D'Alessio, A; Pinato, Dj; Bettinger, D; Binder, H; John Wherry, E; Schultheiss, M; Thimme, R; Bengsch, B. | |
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma | 1-gen-2022 | Muhammed, A.; D'Alessio, A.; Enica, A.; Talbot, T.; Fulgenzi, C. A. M.; Nteliopoulos, G.; Goldin, R. D.; Cortellini, A.; Pinato, D. J. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile